You are here

Home Publications

Publications

Combine Filters and Search to find Publications more quickly

IHPA Work Program 2020–21

29 June 2020

As prescribed in Section 225 of the National Health Reform Act 2011, the objectives of the IHPA Work Program are to:

  • set out IHPA’s work program for the coming year; and
  • invite interested persons (including states and territories) to make submissions to the Pricing Authority about the Work Program up to 30 days after publication.

An extract of Section 225 of the Act is attached at Appendix 1.

Chimeric antigen receptor T cell therapy (CAR-T cell): guidelines for costing, counting and reconciliation of funding

18 June 2020

The guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults (up to 25 years) with Acute Lymphoblastic Leukaemia (ALL) who relapse or do not respond to initial therapy.